<DOC>
	<DOCNO>NCT02528539</DOCNO>
	<brief_summary>Introduction : Breast cancer woman treat axillary node dissection increase risk lymphedema - lifetime risk woman estimate 15-50 % risk significantly increase chemotherapy radiation therapy Objectives : 1 . To evaluate feasibility effectiveness implement integrative therapy program ( ITP ) intervention . ITP consist self-management education conjunction acupuncture . 2 . To determine ITP affect quality life , self-efficacy , lymphedema knowledge , pain , early detection management lymphedema . Design : exploratory study aim evaluate feasibility benefit integrative therapy program ( ITP ) intervention post-operatively 18 month . Subjects : Women breast cancer treat axillary node dissection normal baseline pre-operative bioimpedance ( L-dex U400 ) score . Sample size : 30 subject</brief_summary>
	<brief_title>Prevention Lymphedema Among Breast Cancer Patients Through Implementation Integrative Therapy Program ( ITP )</brief_title>
	<detailed_description>Recruitment Intervention : The study participant recruit breast surgeon undergo axillary node dissection surgery . 4-6 week follow surgery , participant receive combination acupuncture self management education . Contents self-management education include : 1 . Lymphedema knowledge : function lymphatic system , anatomy lymph node direction lymphatic drainage , risk factor could precipitate lymphedema , sign symptom lymphedema infection , lymphedema resource . 2 . Selfcare technique : healthy diet ( eat whole food encourage ) , neck , shoulder chest wall stretching exercise , walk daily , self-manual lymphatic drainage deep breathing technique , self-acupressure eighteen month follow surgery . Outcome measurement include : L-Dex U400 measurement , arm circumference , pain scale , self-efficacy , lymphedema knowledge , Functional Assessment Cancer Therapy-Breast FACT-B .</detailed_description>
	<mesh_term>Lymphedema</mesh_term>
	<criteria>1 . Subjects must able read understand inform consent form capacity give consent . 2 . Adults age 18 old 3 . Subject newly diagnose stage IIII breast cancer document preoperative baseline LDex U400 underwent axillary lymph node dissection within 46 week prior enrollment . 4 . Subjects must able return study site duration study ( 18 month ) . 1 . Subjects read understand inform consent ineligible . 2 . Subjects contraindication affect upperlimb exercise , include congestive heart failure , cardiac arrhythmia , deep vein thrombosis , infectious disease complication cellulitis lymphangitis . 3 . Women double mastectomy axillary node dissection bilaterally . 4 . Women prior history axillary surgery ipsilateral side and/or primary lymphedema 5 . Women metal implant ( e.g . shoulder replacement ) cardiac implant ( e.g . automate implanted cardiac defibrillator ( AICD ) pacemaker ) . 6 . All subject objective subjective sign symptom lymphedema . 7 . Women childbearing age pregnant .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Prevention</keyword>
	<keyword>lymphedema</keyword>
	<keyword>acupuncture</keyword>
	<keyword>self-management</keyword>
</DOC>